Brief: Novogen says patent covering Cantrixil and Trilexium has been granted in Australia

Kazia Therapeutics

19/02/2016 05:14

Feb 19 (Reuters) - Novogen Ltd  NRT.AX : 
 * A patent for superbenzopyran family, covering the lead candidates cantrixil 
   and trilexium, has been granted in Australia 
 * Patent provides full protection of Novogen's intellectual property for the 
   sbp family until 2035 
 * Also,key patent application for first lead anti-tropomyosin compound, 
   anisina, has been examined and accepted by Australian patent office 
 * Source text for Eikon  urn:newsml:reuters.com:*:nPn6Q10yG 
 * Further company coverage  NRT.AX   
 ((Bengaluru Newsroom; +1 646 223 8780))